Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Hydrazine hydrate (1:1) | HCID 24654 | — |
| Reactant | Boron tribromide | HCID 25134 | — |
| Reactant | HCID 18442433 | HCID 18442433 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 18442432 | HCID 18442432 | 80% |
Reaction Steps
To a solution of 1,1-dioxo-3,3-dibutyl-5-(4-chlorophenyl)-7-methylthio-8-methoxy-2,3,4,5-tetrahydro-1,5-benzothiazepine (Method 98; 0.26 g 0.52 mmol) in anhydrous DCM (10 ml) was added boron tribromide (2.63 g, 10.48 mmol) under nitrogen. The reaction mixture was stirred at room temperature for 2.5 h. The reaction flask was cooled to 0° C., water (20 ml) and hydrazine monohydrate (0.5 ml) was added. The organic layer was separated, dried and evaporated under reduced pressure. The crude product was purified by column chromatography using DCM/EtOAc (100:5 and 100:10) as eluent to give the title compound 0.20 g (80%). NMR (500 MHz) 0.85 (t, 6H), 1.03–1.28 (m, 8H), 1.35–1.46 (m, 4H), 2.39 (s, 3H), 3.21 (s, 2H), 3.73 (s, 2H), 7.04 (d, 2H), 7.29–7.34 (m, 3H), 7.44 (s, 1H); m/z 482.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07192945B2 |
|---|
| Source dataset | uspto-grants-2007_03 |
|---|
| ORD ID | ord-aaa3f4c7fb3f4690aaf96d9001d988c8 |
|---|
| Source note | uspto-grants-2007_03 |
|---|